Home > Healthcare > Pharmaceuticals > Clinical Nutrition > U.S. Urology Supplements Market
U.S. urology supplements market size was valued at around USD 755.6 million in 2023 and is expected to exhibit growth at a CAGR of 6.2% from 2024 to 2032. Increasing prevalence of urological disorders such as benign prostatic hyperplasia (BPH), urinary tract infections (UTIs), and interstitial cystitis is a major factor. Moreover, the consumer shift towards preventive healthcare is also projected to have positive impact on the market growth.
Moreover, the U.S. urology supplements industry is driven by the rising prevalence of urological disorders linked to aging, lifestyle factors, and heightened health awareness. Urological conditions such as benign prostatic hyperplasia (BPH), urinary tract infections (UTIs), kidney stones, and erectile dysfunction (ED) are becoming more common, particularly among the aging population. For instance, according to the University of Florida Health research in 2024, kidney stone disease affects approximately one in every 500 individuals in the U.S. each year. Over a lifetime, 1 in 8 men (peak incidence of 40-60 years) and 1 in 16 women (peak incidence 20-50 years) develop this disease.
Furthermore, advancements in product formulations and delivery systems are critical drivers of the U.S. urology supplements market, greatly enhancing efficacy, consumer satisfaction, and overall market growth. Innovations in formulation technologies have led to supplements with improved bioavailability, precise targeted delivery, and synergistic ingredient combinations, addressing specific urological health concerns more effectively.
Urology supplements refer to dietary supplements, herbal remedies, and nutritional products formulated to support urinary tract health, prostate function, and overall urological wellness. These supplements typically contain a combination of vitamins, minerals, herbal extracts, antioxidants, and other ingredients that are believed to promote urinary health, alleviate urological symptoms, and reduce the risk of urological disorders.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
U.S. Urology Supplements Market Size in 2023: | USD 755.6 Million |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 6.2% |
2024 – 2032 Value Projection: | USD 1.3 Billion |
Historical Data for: | 2021 – 2023 |
No. of Pages: | 80 |
Tables, Charts & Figures: | 23 |
Segments covered: | Type, Application, Formulation, and Distribution Channel |
Growth Drivers: |
|
Pitfalls & Challenges: |
|